107 related articles for article (PubMed ID: 27987711)
1. Folic acid-modified soy protein nanoparticles for enhanced targeting and inhibitory.
Cheng X; Wang X; Cao Z; Yao W; Wang J; Tang R
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():298-307. PubMed ID: 27987711
[TBL] [Abstract][Full Text] [Related]
2. Folic acid modified cell membrane capsules encapsulating doxorubicin and indocyanine green for highly effective combinational therapy in vivo.
Li X; Zhao X; Pardhi D; Wu Q; Zheng Y; Zhu H; Mao Z
Acta Biomater; 2018 Jul; 74():374-384. PubMed ID: 29734009
[TBL] [Abstract][Full Text] [Related]
3. 3-Carboxyphenylboronic acid-modified carboxymethyl chitosan nanoparticles for improved tumor targeting and inhibitory.
Wang X; Wei B; Cheng X; Wang J; Tang R
Eur J Pharm Biopharm; 2017 Apr; 113():168-177. PubMed ID: 28089786
[TBL] [Abstract][Full Text] [Related]
4. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
5. Folic acid-conjugated soybean protein-based nanoparticles mediate efficient antitumor ability in vitro.
Yao W; Zha Q; Cheng X; Wang X; Wang J; Tang R
J Biomater Appl; 2017 Jan; 31(6):832-843. PubMed ID: 27881641
[TBL] [Abstract][Full Text] [Related]
6. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
Wu G; Wang Z; Bian X; Du X; Wei C
Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652
[TBL] [Abstract][Full Text] [Related]
7. Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery.
Song H; Su C; Cui W; Zhu B; Liu L; Chen Z; Zhao L
Biomed Res Int; 2013; 2013():723158. PubMed ID: 24282819
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles.
Wang X; Zhen X; Wang J; Zhang J; Wu W; Jiang X
Biomaterials; 2013 Jun; 34(19):4667-79. PubMed ID: 23537667
[TBL] [Abstract][Full Text] [Related]
9. Acid-degradable lactobionic acid-modified soy protein nanogels crosslinked by ortho ester linkage for efficient antitumor in vivo.
Cheng X; Qin J; Wang X; Zha Q; Yao W; Fu S; Tang R
Eur J Pharm Biopharm; 2018 Jul; 128():247-258. PubMed ID: 29730261
[TBL] [Abstract][Full Text] [Related]
10. Development and application of nanoparticles synthesized with folic acid conjugated soy protein.
Teng Z; Luo Y; Wang T; Zhang B; Wang Q
J Agric Food Chem; 2013 Mar; 61(10):2556-64. PubMed ID: 23414105
[TBL] [Abstract][Full Text] [Related]
11. pH-triggered chitosan nanogels via an ortho ester-based linkage for efficient chemotherapy.
Yang G; Wang X; Fu S; Tang R; Wang J
Acta Biomater; 2017 Sep; 60():232-243. PubMed ID: 28479490
[TBL] [Abstract][Full Text] [Related]
12. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
Zhang C; Zhang Z; Zhao L
Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
[TBL] [Abstract][Full Text] [Related]
13. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
Zhang C; Wu Y; Dong Y; Xu H; Zhao L
Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
[TBL] [Abstract][Full Text] [Related]
14. pH-Sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo-photodynamic combination therapy.
Hou W; Zhao X; Qian X; Pan F; Zhang C; Yang Y; de la Fuente JM; Cui D
Nanoscale; 2016 Jan; 8(1):104-16. PubMed ID: 26607263
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
16. Phenylboronic acid-decorated gelatin nanoparticles for enhanced tumor targeting and penetration.
Wang X; Wei B; Cheng X; Wang J; Tang R
Nanotechnology; 2016 Sep; 27(38):385101. PubMed ID: 27514078
[TBL] [Abstract][Full Text] [Related]
17. Self-assembly of folic acid dextran conjugates for cancer chemotherapy.
Tang Y; Li Y; Xu R; Li S; Hu H; Xiao C; Wu H; Zhu L; Ming J; Chu Z; Xu H; Yang X; Li Z
Nanoscale; 2018 Sep; 10(36):17265-17274. PubMed ID: 30191943
[TBL] [Abstract][Full Text] [Related]
18. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
